@article{eb119120820440fcb167a5452048c456,
title = "Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study)",
abstract = "To evaluate the efficacy of different dosing paradigms of PF-04523655 (PF) versus ranibizumab (comparator) in subjects with neovascular age-related macular degeneration (AMD).",
keywords = "Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Choroidal Neovascularization, Drug Therapy, Combination, Female, Fluorescein Angiography, Humans, Intravitreal Injections, Male, Middle Aged, Prospective Studies, RNA Interference, RNA, Small Interfering, Retina, Tomography, Optical Coherence, Treatment Outcome, Visual Acuity, Wet Macular Degeneration",
author = "Nguyen, {Quan Dong} and Schachar, {Ronald A} and Nduaka, {Chudy I} and Marvin Sperling and Klamerus, {Karen J} and Katherine Chi-Burris and Eric Yan and Paggiarino, {Dario A} and Irit Rosenblatt and Roger Aitchison and Erlich, {Shai S} and {MONET Clinical Study Group} and Michael Larsen",
note = "Copyright {\textcopyright} 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.",
year = "2012",
doi = "10.1016/j.ophtha.2012.03.043",
language = "English",
volume = "119",
pages = "1867--73",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc",
number = "9",
}